| Literature DB >> 35949468 |
Mesmin Dehayem Yefou1,2, Ahmadou Musa Jingi3, Martine Claude Etoa Etoga1,2, Francine Mendane Mekobe1, Batakeh Ba Agoons4, Eliane Ngassam1, Eugène Sobngwi1,2, Jean-Claude Mbanya1,2.
Abstract
Introduction: bacterial profile of diabetic foot infections and the antibiotic susceptibility are essential in the prescription of empirical antibiotics before the results of cultures of deep wound samples are available. The aim of this study was to determine the microbiological profile and antibiotic susceptibility of bacteria isolated from infected diabetic foot ulcers in patients attending the Yaoundé Central Hospital, Cameroon.Entities:
Keywords: Diabetic foot infections; antibiotic susceptibility
Mesh:
Substances:
Year: 2022 PMID: 35949468 PMCID: PMC9307920 DOI: 10.11604/pamj.2022.42.52.31042
Source DB: PubMed Journal: Pan Afr Med J
baseline characteristics of the study population and outcome (n = 101 patients)
| Age, mean ± SD (years) | 57.1 ± 9.1 |
|---|---|
|
| |
| Type 1 | 1 (1) |
| Type 2 | 100 (99) |
|
| 9 [4 - 14] |
|
| 246 [177 - 381] |
|
| |
| Hypertension | 44 |
| Dyslipidemia | 71 |
| Tobacco consumption (recent) | 20 |
| Diabetic retinopathy | 61 |
| Diabetic nephropathy | 52 |
| Diabetic neuropathy | 95 |
| Peripheral arterial disease | 38 |
|
| 14 [10 - 30] |
|
| 82 |
|
| 79 |
|
| 31.5 [21 - 43] |
|
| |
| Death | 5 |
| Major amputations | 23 |
| IQR: Interquartile range | |
profile of bacteria isolated from patients with diabetic foot infections (n = 101 patients)
| Bacteria category | Frequency (percentage) |
|---|---|
| Number of isolates | 225 |
| Gram-negative bacteria | |
|
| 31 (13.8) |
|
| 27 (12.0) |
|
| 26 (11.6) |
| 24 (10.7) | |
|
| 20 (8.9) |
| 13 (5.8) | |
| 8 (3.5) | |
| 6 (2.7) | |
| 4 (1.8) | |
| Others | 10 (4.4) |
| Total | 169 (75.2) |
| Gram-positive bacteria | |
| 21 (9.3) | |
| 17 (7.6) | |
| 16 (7.1) | |
| Others | 2 (0.8) |
| Total | 56 (24.8) |
antimicrobial susceptibility of Gram-negative bacteria isolated from patients with diabetic foot infections (n = 101 patients)
| Antibiotic | Proportion susceptible (%) | ||||
|---|---|---|---|---|---|
|
|
|
|
| ||
| Amoxicillin-clavulanic acid | 0/30 (0) | 5/24 (21) | 4/26 (15) | 17/21(81) | - |
| Gentamicin | 16/29 (55) | 7/20 (35) | 5/17 (29) | 18/23 (78%) | 12/19 (63) |
| Amikacin | 30/30 (100) | 20/26 (77) | 21/26 (81) | 21/24 (88) | 15/19 (79) |
| Imipenem | 16/19 (84) | 18/19 (95) | 21/21 (100) | 14/15 (93) | 10/11 (91) |
| Cefotaxime | 23/27 (85) | 9/17 (53) | 14/25 (56) | 20/22 (91) | - |
| Ceftazidime | 24/27 (89) | 9/23 (39) | 14/22 (63) | 23/24 (95) | 14/17 (82) |
| Ciprofloxacin | 10/21 (35) | 9/26 (35) | 5/25 (20) | 18/23 (78) | 9/15 (60) |
| Co-trimoxazole | 5/31 (16) | 2/27 (7) | 4/25 (19) | 12/23 (52) | 1/14 (71) |
| Ticarcillin | 12/30 (40) | 26/26 (100) | 2/26 (8) | 12/19 (63) | 6/16 (38) |
The proportion susceptible represents the number of bacteria susceptible by the number of bacteria tested
antimicrobial susceptibility of Gram-positive bacteria isolated from patients with diabetic foot ulcer infections (n= 101 patients)
| Antibiotic | Susceptibility (%) | ||
|---|---|---|---|
|
| |||
| Oxacillin | 10/21 (48) | - | - |
| Amikacin | 19/21 (90) | - | - |
| Vancomycin | 18/21 (86) | 16/16 (100) | 13/13 (100) |
| Erythromycin | 12/18 (67) | 3/7 (43) | 9/13 (70) |
| Lincomycin | 11/17 (65) | - | - |
| Rifampicin | 4/5 (80) | - | - |
| Pristinamycin | 17/20 (85) | 4/6 (67) | 2/2 (100) |
| Fusidic acid | 12/18 (67) | - | - |
| Co-trimoxazole | 12/17 (71) | 6/17 (35) | 1/16 (6) |
The proportion susceptible represents the number of bacteria susceptible by the number of bacteria tested